The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease.
The agent has shown pronounced immune-modulating effects, particularly in suppressing the activity of T and NK cells, and is currently under investigation for its potential use in treating psoriasis and preventing graft-versus-host disease.